Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.12.6277

A 10-year Study of Esophageal Cancer in Guilan Province, Iran: The Guilan Cancer Registry Study (GCRS)  

Mansour-Ghanaei, Fariborz (Medicine Department, Guilan University of Medical Sciences)
Heidarzadeh, Abtin (Gastrointestinal and Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences)
Naghipour, Mohammad Reza (Gastrointestinal and Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences)
Joukar, Farahnaz (Gastrointestinal and Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences)
Valeshabad, Ali Kord (Gastrointestinal and Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences)
Fallah, Mohammad-Sadegh (Gastrointestinal and Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences)
Rezvani, Seyed Mahmoud (Health Department, Guilan University of Medical Sciences)
Sedigh-Rahimabadi, Massih (Gastrointestinal and Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences)
Rokhshad, Hasan (Health Department, Guilan University of Medical Sciences)
Dadashi, Arsalan (Health Department, Guilan University of Medical Sciences)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.12, 2012 , pp. 6277-6283 More about this Journal
Abstract
Background: Northern Iran counts as one of the highest prevalence regions for esophageal cancer (EC) worldwide. This study was designed to assess the epidemiologic aspects of EC in north central and northwest Iran over a 10 year period. Materials and Methods: The Guilan cancer registry study (GCRS) is a population-based cancer registry study featuring retrospective (1996-2003) and prospective (2004-2005) phases. A detailed questionnaire based on WHO standards for cancer registratration was applied to gather the required information. Two trained physicians coded information using ICD-O-3 in close coordination with an expert pathologist. Results: A total of 19,936 cases of malignancy (mean age $55.4{\pm}18.0$ years, range: 1-98 years) were registered, including 1,147 cases (670 males, 447 female; mean age: $64.0{\pm}11.5$ years) of EC. In 1996 the male/female ratio among patients with EC was 1.25 which increased to 1.53 in 2005. The lower third of the esophagus still remained the most common site of tumors. The average age-standardized rate (ASR) was 6.9 and 4.1 per $10^5$ men and women, respectively. In 1996, the ASRs were 7.2 and 5.2 per $10^5$ men and women which decreased to 6.9 and 4.1 per $10^5$ in 2004-2005. Squamous cell carcinoma (SCC) was the most prevalent histological subtype of EC accounting over 80% of cases. Conclusions: However the prevalence of adenocarcinoma (ADC) showed an increase to 18.4%. Guilan province may be considered a relatively low incidence region for EC.
Keywords
Esophageal cancer; cancer registry study (GCRS); Guilan; Iran;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Yang CX, Wang HY, Wang ZM, et al (2005). Risk factors for esophageal cancer: a case control study in southwestern China. Asian Pac J Cancer Prev, 6, 48-53.
2 Zaridze DG, Basieva T, Kabulov M, et al (1992). Oesophageal cancer in the Republic of Karakal pakstan. Int J Epidemiol, 21, 643-8.   DOI
3 Kamangar F, Malekzadeh R, Dawsey SM, et al (2007). Esophageal cancer in northeastern Iran: A review. Arch Iran Med, 10, 70-82.
4 Ke L (2002). Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90. Int J Cancer, 102, 271-4.   DOI   ScienceOn
5 Kmet J, Mahboubi E (1972). Esophageal cancer in the Caspian littoral of Iran: initial studies. Science, 175, 846-53.   DOI   ScienceOn
6 Kollarova H, Machova L, Horakova D, et al (2007). Epidemiology of esophageal cancer--an overview article. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 151, 17-20.   DOI
7 Mahboubi E (1971). Epidemiologic study of esophageal carcinoma in Iran. Int Surg, 56, 68-71.
8 Mahboubi E, Kmet J, Cook PJ, et al (1973).Oesophageal cancer studies in the Caspian littoral of Iran: the Caspian cancer registry. Br J Cancer, 28, 197-214.   DOI   ScienceOn
9 Malaveille C, Friesen M, Camus AM, et al (1982). Mutagens produced by the pyrolysis of opium and its alkaloids as possible risk factors in cancer of the bladder and oesophagus. Carcinogenesis, 3, 577-85.   DOI   ScienceOn
10 Malekzadeh R, Mohamadnejad M, Merat S, et al (2005). Obesity pandemic: an Iranian perspective. Arch Iran Med, 8, 1-7.
11 Malekzadeh R, Nasseri-Moghaddam S, Sotoudeh M (2003). Gastroesophageal reflux disease: the new epidemic. Arch Iran Med, 6, 127-40.
12 Hossein SM, Mirinezhad K, Farhang S, et al (2006). Gastrointestinal cancer occurrence in East Azarbaijan: a five year study from North Western Iran. Asian Pac J Cancer Prev, 7, 309-12.
13 Islami F, Pourshams A, Nasrollahzadeh D, et al (2009). Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ, 338, 929.   DOI   ScienceOn
14 Jakszyn P, Gonzalez CA (2006). Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J Gastroenterol, 12, 4296-303.
15 Jansson C, Johansson AL, Nyren O, et al (2005). Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study. Cancer Epidemiol Biomarkers Prev, 14, 1754-61.   DOI   ScienceOn
16 Kairakbaev MK (1978). Malignant neoplasms among ethnic groups in the Kazakh SSR. Vopr Onkol, 24, 100-4.
17 Babaei M, Mousavi S, Malek M, et al (2005). Cancer occurrence in Semnan Province, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev, 6, 159-64.
18 Kamangar F, Dores GM, Anderson WF (2006). Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 24, 2137-50.   DOI   ScienceOn
19 Sadjadi A, Nouraie M, Mohagheghi MA, et al (2005). Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev, 6, 359-63.
20 Sadjadi A, Zahedi M, Moghadam S, et al (2007). The first population based cancer survey in Kerman Province of Iran. Iran J Public Hlth, 36, 26-34.
21 Sadjadi A, Malekzadeh R, Derakhshan MH, et al (2003). Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer, 107, 113-8.   DOI   ScienceOn
22 Saenko AI (1975). The epidemiology of cancer in Central Asia. Vopr Onkol, 21, 40-4.
23 Saidi F, Sepehr A, Fahimi S, et al (2000). Oesophageal cancer among the Turkomens of North-East Iran. Br J Cancer, 83, 1249-54.   DOI   ScienceOn
24 Samadi F, Babaei M, Yazdanbod A, et al (2007). Survival rate of gastric and esophageal cancers in Ardabil province, North- West of Iran. Arch Iran Med, 10, 32-7.
25 Semnani S, Sadjadi A, Fahimi S, et al (2006). Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev, 30, 14-29.   DOI   ScienceOn
26 Sepehr A, Kamangar F, Fahimi S, et al (2005). Poor oral health as a risk factor for esophageal squamous dysplasia in northeastern Iran. Anticancer Res, 25, 543-6.
27 Sepehr A, Razavi P, Saidi F, et al (2000). Esophageal exfoliative cytology samplers. A comparison of three types. Acta Cytol, 44, 797-804.   DOI   ScienceOn
28 Naghavi M (2000). Death report from 10 provinces in Iran. Tehran, Ministry of Health.
29 Mohebbi M, Mahmoodi M, Wolfe R, et al (2008). Geographical spread of gastrointestinal tract cancer incidence in the Caspian Sea region of Iran: spatial analysis of cancer registry data. BMC Cancer, 8, 137.   DOI   ScienceOn
30 Moradi A, Kalavi K, Qujeq D, et al (2007). Risk factors of esophageal cancer in Turkmen Sahra of Iran. TJC, 37, 16-21.
31 Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.   DOI   ScienceOn
32 Perry PE, Thomson EJ, Vijayalaxm I, et al (1983). Induction of SCE by opium pyrolysates in CHO cells and human peripheral blood lymphocytes. Carcinogenesis, 4, 227-30.   DOI   ScienceOn
33 Pourshams A, Khademi H, Malekshah AF, et al (2010). Cohort profile: the golestan cohort study--a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol, 39, 52-9.   DOI   ScienceOn
34 Roth M, Qiao Y, Rothman N, et al (2001). High urine 1-hydroxypyrene glucoronide concentration in Linxian, China, an area of high risk for squamous oesophageal cancer. Biomarkers, 6, 381-6.   DOI   ScienceOn
35 Sadjadi A, Marjani H, Semnani S, et al (2010). Esophageal Cancer in Iran: A Review. Middle East J Cancer, 1, 5-14.
36 Baquet CR, Commiskey P, Mack K, et al (2005). Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc, 97, 1471-8.
37 Brown LM, Devesa SS (2002). Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am, 11, 235-56.
38 Derakhshan MH, Malekzadeh R, Watabe H, et al (2008). Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut, 57, 298-305.   DOI   ScienceOn
39 Brown LM, Hoover R, Silverman D, et al (2001). Excess incidence of squamous cell esophageal cancer among U.S. Black men: role of social class and other risk factors. Am J Epidemiol, 153, 114-22.   DOI   ScienceOn
40 Castellsague X, Munoz N, De Stefani E, et al (2000). Influence of mate drinking, hot beverages, and diet on esophageal cancer risk in South America. Int J Cancer, 88, 658-64.   DOI   ScienceOn
41 Eser S, Yakut C, Özdemir R, et al (2010). Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev, 11, 1731-9.
42 Ghadirian P (1987). Thermal irritation and esophageal cancer in northern Iran. Cancer, 60, 1909-14.   DOI   ScienceOn
43 Ghadirian P, Stein GF, Gorodetzky C, et al (1985). Oesophageal cancer studies in the Caspian littoral of Iran: some residual results, including opium use as a risk factor. Int J Cancer, 35, 593-7.   DOI
44 Gonzalez CA, Pera G, Agudo A, et al (2006). Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer, 118, 2559-66.   DOI   ScienceOn
45 Haghdoost AA, Hosseini H, Chamani G, et al (2008). Rising incidence of adenocarcinoma of the esophagus, in Kerman. Arch Iran Med, 11, 364-70.
46 Hewer T, Rose E, Ghadirian P, et al (1978). Ingested mutagens from opium and tobacco pyrolysis products and cancer of the oesophagus. Lancet, 2, 494-6.